60 Degrees Pharma announces 1-for-4 reverse stock split; shares up [Seeking Alpha]
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State [Yahoo! Finance]
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State